CN1067811A - 利用透过皮肤来吸收尼古丁的投药组包及方法 - Google Patents

利用透过皮肤来吸收尼古丁的投药组包及方法 Download PDF

Info

Publication number
CN1067811A
CN1067811A CN 92105287 CN92105287A CN1067811A CN 1067811 A CN1067811 A CN 1067811A CN 92105287 CN92105287 CN 92105287 CN 92105287 A CN92105287 A CN 92105287A CN 1067811 A CN1067811 A CN 1067811A
Authority
CN
China
Prior art keywords
nicotine
group bag
dispensing group
skin
acid ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN 92105287
Other languages
English (en)
Chinese (zh)
Inventor
姜钦治
吴日丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TBS Laboratories Inc
Original Assignee
TBS Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TBS Laboratories Inc filed Critical TBS Laboratories Inc
Publication of CN1067811A publication Critical patent/CN1067811A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN 92105287 1991-06-26 1992-06-26 利用透过皮肤来吸收尼古丁的投药组包及方法 Withdrawn CN1067811A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72112991A 1991-06-26 1991-06-26
US721,129 1991-06-26

Publications (1)

Publication Number Publication Date
CN1067811A true CN1067811A (zh) 1993-01-13

Family

ID=24896654

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 92105287 Withdrawn CN1067811A (zh) 1991-06-26 1992-06-26 利用透过皮肤来吸收尼古丁的投药组包及方法

Country Status (6)

Country Link
EP (1) EP0544900A4 (ja)
CN (1) CN1067811A (ja)
AU (1) AU2294192A (ja)
CA (1) CA2094913A1 (ja)
TW (1) TW221970B (ja)
WO (1) WO1993000057A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1951375B (zh) * 2005-10-13 2010-11-03 日东电工株式会社 烟碱透皮制剂及其生产方法
CN104083344A (zh) * 2005-06-21 2014-10-08 日东电工株式会社 烟碱经皮递送系统

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7323794A (en) * 1993-07-09 1995-02-06 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
EP2377540A1 (en) * 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CH672888A5 (ja) * 1986-11-07 1990-01-15 Mepha Ag
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104083344A (zh) * 2005-06-21 2014-10-08 日东电工株式会社 烟碱经皮递送系统
CN1951375B (zh) * 2005-10-13 2010-11-03 日东电工株式会社 烟碱透皮制剂及其生产方法

Also Published As

Publication number Publication date
WO1993000057A1 (en) 1993-01-07
TW221970B (ja) 1994-04-01
EP0544900A1 (en) 1993-06-09
EP0544900A4 (en) 1993-12-01
AU2294192A (en) 1993-01-25
CA2094913A1 (en) 1992-12-27

Similar Documents

Publication Publication Date Title
US5641504A (en) Skin permeation enhancer compositions using glycerol monolinoleate
DK175580B1 (da) Transdermal absorptionsdosisenhed til narkotiske analgetika og antagonister
RU2428186C2 (ru) Лекарственная композиция для чрескожной абсорбции, изделие, сохраняющее лекарственную композицию, и содержащий ее препарат для чрескожной абсорбции
CN100374161C (zh) 透皮促进剂甘油三醋酸酯
JP3021661B2 (ja) 薬剤含有接着複合体の経皮放出デバイス
CA2550704C (en) Nicotine transdermal delivery system
JP4628673B2 (ja) 活性成分フェンタニルを含む経皮治療システム（ｔｔｓ）
PH27001A (en) Transdermal monolith system
PL165396B1 (en) Method of obtaining a percutaneous therapeutic system containing bupernophyne as an active substance
EP2269653A1 (en) Composition for stabilizing -blocker, and transdermally absorbable preparation comprising the composition
WO1992020377A1 (en) Skin permeation enhancer compositions using glycerol monolinoleate
EP2457570B1 (en) Fentanyl-containing adhesive preparation for external use
EP1938808B1 (en) Preparation for external use comprising tamsulosin
JP2016069287A (ja) リバスチグミン含有経皮吸収型貼付製剤
JPH08508266A (ja) 皮膚へのエストラジオール放出用活性物質パッチ
KR102499141B1 (ko) 수면장애 치료용 경피흡수제제
EP2671572B1 (en) Patch and patch preparation
CN1067811A (zh) 利用透过皮肤来吸收尼古丁的投药组包及方法
EP2671573B1 (en) Patch and patch preparation
JP6100948B2 (ja) 貼付製剤
WO2020260727A1 (en) Transdermal therapeutic system containing agomelatine
CN1929827A (zh) 包含至少一种脂肪酸的用于二氢吡啶类钙拮抗剂的经皮递送装置
CN113677343B (zh) 生物体对药物的吸收性优异且化学稳定性也优异的医药组合物
DK175236B1 (da) Farmaceutisk præparat
US20210290560A1 (en) Transdermal therapeutic system for dispensing scopolamine without a membrane

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C03 Withdrawal of patent application (patent law 1993)
WW01 Invention patent application withdrawn after publication